Voxalatamab, CAS 2411871-58-2

Product Description: Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Jonas S Heitmann, et al. Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives. Cancers (Basel). 2021 Feb 1;13(3):549.

CAS Number: 2411871-58-2

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD3

• Artikelnummer: MEXHY-P99517-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99517-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated